Engineering an enhanced thrombin-based GLP-1 analog with long-lasting glucose-lowering and efficient weight reduction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering an enhanced thrombin-based GLP-1 analog with long-lasting glucose-lowering and efficient weight reduction

Published:2019 Issue:53 Volume:9 Page:30707-30714
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Pan Hongchao¹²³⁴,Xie Yini¹⁵⁶⁷,Lu Wenying⁸⁹¹⁰⁷,Chen Yin¹¹¹²¹³⁷,Lu Zhao¹⁴¹⁵¹⁶⁷,Zhen Jun¹⁴¹⁵¹⁶⁷,Wang Weiwei⁸⁹¹⁰⁷^ORCID,Shang Anquan¹¹⁷¹⁸⁷^ORCID

Affiliation:

1. Department of Laboratory Medicine

2. Shanghai Simple Gene Medical Laboratory

3. Shanghai 200025

4. P.R. China

5. The People's Hospital of Jiedong

6. Jieyang 515500

7. P. R. China

8. Department of Experimental Medicine Center

9. The Sixth People's Hospital of Yancheng City

10. Yancheng 224001

11. Key Laboratory of Biological Medicine

12. Department of Life Science and Technology

13. Jinan University

14. Key Laboratory of Drug Discovery for Metabolic Disease

15. China Pharmaceutical University

16. Nanjing

17. Tongji Hospital of Tongji University

18. Shanghai 200065

Abstract

Peptides are considered as potent therapeutic drugs primarily due to the exquisite potency and selectivity to targets.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/RA/C9RA06771J

Reference38 articles.

1. Opportunities and Challenges of Developing Peptide Drugs in the Pharmaceutical Industry

2. Protein, peptide and non-peptide drug PEGylation for therapeutic application

3. Peptide and protein drugs: I. Therapeutic applications, absorption and parenteral administration

4. Neuropeptides, Hormone Peptides, and Their Receptors inCiona intestinalis:An Update

5. Characterisation of the Binding Sites of Anti-Parathyroid Hormone Antisera Using Synthetic Parathyroid Hormone Peptides

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dulaglutide Ameliorates Intrauterine Adhesion by Suppressing Inflammation and Epithelial–Mesenchymal Transition via Inhibiting the TGF-β/Smad2 Signaling Pathway;Pharmaceuticals;2023-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3